Filing Details
- Accession Number:
- 0001209191-16-147941
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-02 16:54:37
- Reporting Period:
- 2016-10-31
- Filing Date:
- 2016-11-02
- Accepted Time:
- 2016-11-02 16:54:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1481512 | Ra Pharmaceuticals Inc. | RARX | () | G7 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1388325 | A/S Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-10-31 | 924,970 | $0.00 | 924,970 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2016-10-31 | 860,438 | $0.00 | 1,785,408 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2016-10-31 | 246,154 | $13.00 | 2,031,562 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B-1 Preferred Stock | Disposition | 2016-10-31 | 924,970 | $0.00 | 924,970 | $0.00 |
| Common Stock | Series B-2 Preferred Stock | Disposition | 2016-10-31 | 860,438 | $0.00 | 860,438 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series B-1 Preferred Stock and Series B-2 Preferred Stock (the "Preferred Stock") has no expiration date and is convertible at any time at the holder's election. Upon the closing of the Issuer's initial public offering, the Preferred Stock automatically converted on a one-for-one basis for no additional consideration into common stock.
- Represents a purchase from the underwriters in the Issuer's public offering.
Billionaire Hedge Funds
